A medtech innovator in molecular pathology
Xyall has raised €14M across 2 funding rounds from 7 investors, most recently a round in Feb 2026. Based in Eindhoven, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
